The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study
Copyright © 2021. Published by Elsevier Ltd..
OBJECTIVES: Recently emerging SARS-CoV-2 variants have been associated with an increased rate of transmission within the community. We sought to determine whether this also resulted in increased transmission within hospitals.
METHODS: We collected viral sequences and epidemiological data of patients with community and healthcare associated SARS-CoV-2 infections, sampled from 16th November 2020 to 10th January 2021, from nine hospitals participating in the COG-UK HOCI study. Outbreaks were identified using ward information, lineage and pairwise genetic differences between viral sequences.
RESULTS: Mixed effects logistic regression analysis of 4184 sequences showed healthcare-acquired infections were no more likely to be identified as the Alpha variant than community acquired infections. Nosocomial outbreaks were investigated based on overlapping ward stay and SARS-CoV-2 genome sequence similarity. There was no significant difference in the number of patients involved in outbreaks caused by the Alpha variant compared to outbreaks caused by other lineages.
CONCLUSIONS: We find no evidence to support it causing more nosocomial transmission than previous lineages. This suggests that the stringent infection prevention measures already in place in UK hospitals contained the spread of the Alpha variant as effectively as other less transmissible lineages, providing reassurance of their efficacy against emerging variants of concern.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
The Journal of infection - 83(2021), 6 vom: 05. Dez., Seite 693-700 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Alpha variant |
|---|
| Anmerkungen: |
Date Completed 24.12.2021 Date Revised 04.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2021.09.022 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331516071 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331516071 | ||
| 003 | DE-627 | ||
| 005 | 20240404232628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2021.09.022 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM331516071 | ||
| 035 | |a (NLM)34610391 | ||
| 035 | |a (PII)S0163-4453(21)00493-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Boshier, Florencia A T |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.12.2021 | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021. Published by Elsevier Ltd. | ||
| 520 | |a OBJECTIVES: Recently emerging SARS-CoV-2 variants have been associated with an increased rate of transmission within the community. We sought to determine whether this also resulted in increased transmission within hospitals | ||
| 520 | |a METHODS: We collected viral sequences and epidemiological data of patients with community and healthcare associated SARS-CoV-2 infections, sampled from 16th November 2020 to 10th January 2021, from nine hospitals participating in the COG-UK HOCI study. Outbreaks were identified using ward information, lineage and pairwise genetic differences between viral sequences | ||
| 520 | |a RESULTS: Mixed effects logistic regression analysis of 4184 sequences showed healthcare-acquired infections were no more likely to be identified as the Alpha variant than community acquired infections. Nosocomial outbreaks were investigated based on overlapping ward stay and SARS-CoV-2 genome sequence similarity. There was no significant difference in the number of patients involved in outbreaks caused by the Alpha variant compared to outbreaks caused by other lineages | ||
| 520 | |a CONCLUSIONS: We find no evidence to support it causing more nosocomial transmission than previous lineages. This suggests that the stringent infection prevention measures already in place in UK hospitals contained the spread of the Alpha variant as effectively as other less transmissible lineages, providing reassurance of their efficacy against emerging variants of concern | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Alpha variant | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Lineage B.1.1.7 | |
| 650 | 4 | |a Nosocomial outbreaks | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Transmissibility | |
| 650 | 4 | |a Variants of concern | |
| 700 | 1 | |a Venturini, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Stirrup, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Guerra-Assunção, José Afonso |e verfasserin |4 aut | |
| 700 | 1 | |a Alcolea-Medina, Adela |e verfasserin |4 aut | |
| 700 | 1 | |a Becket, Angela H |e verfasserin |4 aut | |
| 700 | 1 | |a Byott, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Charalampous, Themoula |e verfasserin |4 aut | |
| 700 | 1 | |a Filipe, Ana da Silva |e verfasserin |4 aut | |
| 700 | 1 | |a Frampton, Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Glaysher, Sharon |e verfasserin |4 aut | |
| 700 | 1 | |a Khan, Tabassum |e verfasserin |4 aut | |
| 700 | 1 | |a Kulasegara-Shylini, Raghavendran |e verfasserin |4 aut | |
| 700 | 1 | |a Kele, Beatrix |e verfasserin |4 aut | |
| 700 | 1 | |a Monahan, Irene M |e verfasserin |4 aut | |
| 700 | 1 | |a Mollett, Guy |e verfasserin |4 aut | |
| 700 | 1 | |a Parker, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Pelosi, Emanuela |e verfasserin |4 aut | |
| 700 | 1 | |a Randell, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Roy, Sunando |e verfasserin |4 aut | |
| 700 | 1 | |a Taylor, Joshua F |e verfasserin |4 aut | |
| 700 | 1 | |a Weller, Sophie J |e verfasserin |4 aut | |
| 700 | 1 | |a Wilson-Davies, Eleri |e verfasserin |4 aut | |
| 700 | 1 | |a Wade, Phillip |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Copas, Andrew J |e verfasserin |4 aut | |
| 700 | 1 | |a Cutino-Moguel, Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Freemantle, Nick |e verfasserin |4 aut | |
| 700 | 1 | |a Hayward, Andrew C |e verfasserin |4 aut | |
| 700 | 1 | |a Holmes, Alison |e verfasserin |4 aut | |
| 700 | 1 | |a Hughes, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Mahungu, Tabitha W |e verfasserin |4 aut | |
| 700 | 1 | |a Nebbia, Gaia |e verfasserin |4 aut | |
| 700 | 1 | |a Nastouli, Eleni |e verfasserin |4 aut | |
| 700 | 1 | |a Partridge, David G |e verfasserin |4 aut | |
| 700 | 1 | |a Pope, Cassie F |e verfasserin |4 aut | |
| 700 | 1 | |a Price, James R |e verfasserin |4 aut | |
| 700 | 1 | |a Robson, Samuel C |e verfasserin |4 aut | |
| 700 | 1 | |a Saeed, Kordo |e verfasserin |4 aut | |
| 700 | 1 | |a Shin, Gee Yen |e verfasserin |4 aut | |
| 700 | 1 | |a de Silva, Thushan I |e verfasserin |4 aut | |
| 700 | 1 | |a Snell, Luke B |e verfasserin |4 aut | |
| 700 | 1 | |a Thomson, Emma C |e verfasserin |4 aut | |
| 700 | 1 | |a Witney, Adam A |e verfasserin |4 aut | |
| 700 | 1 | |a Breuer, Judith |e verfasserin |4 aut | |
| 700 | 0 | |a COG-UK HOCI Variant Substudy consortium*, The COVID-19 Genomics UK (COG-UK) consortium |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 83(2021), 6 vom: 05. Dez., Seite 693-700 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2021 |g number:6 |g day:05 |g month:12 |g pages:693-700 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.09.022 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2021 |e 6 |b 05 |c 12 |h 693-700 | ||